Guideline Adherence in Docetaxel Treatment of Castration Resistant Prostate Cancer (CRPC) Patients in a Real-World Population: The Castration Resistant Prostate Cancer Registry (CAPRI) in the Netherlands

Value in Health - United Kingdom
doi 10.1016/j.jval.2017.08.416
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Pcn388 - Patient Reported Outcomes in the Castration Resistant Prostate Cancer Registry (Pro-Capri) in the Netherlands

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Docetaxel Rechallenge in Patients With Castration-Resistant Prostate Cancer — A Review

European Oncology and Haematology
OncologyHematology
2012English

The Treatment Patterns of Castration Resistant Prostate Cancer in Japan

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Pcn336 - Treatment of Metastatic Castration-Resistant Prostate Cancer Patients Previously Treated With Docetaxel in Portugal

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Treatment Registry for Outcomes in Patients With Castration-Resistant Prostate Cancer (TRUMPET): A Methodology for Real-World Evidence and Research

Future Oncology
MedicineCancer ResearchOncology
2016English

Visceral Disease in Castration-Resistant Prostate Cancer

European Urology
Urology
2014English

Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer

Yearbook of Paediatric Endocrinology
2019English

Salvage Therapy for Castration-Refractory Prostate Cancer Resistant to Docetaxel

Japanese Journal of Urology
Urology
2013English

Targeting Cancer Stem Cells in Castration-Resistant Prostate Cancer

Clinical Cancer Research
Cancer ResearchOncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy